---
title: "How Investors Are Reacting To ALS (ASX:ALQ) Earnings And Its Strict 15% ROCE Deal Filter"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/287804765.md"
description: "How Investors Are Reacting To ALS (ASX:ALQ) Earnings And Its Strict 15% ROCE Deal Filter"
datetime: "2026-05-27T17:23:37.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/287804765.md)
  - [en](https://longbridge.com/en/news/287804765.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/287804765.md)
generator: "portal-rs"
---

# How Investors Are Reacting To ALS (ASX:ALQ) Earnings And Its Strict 15% ROCE Deal Filter

-   ALS Limited (ASX:ALQ) recently reported full-year results to March 31, 2026, with revenue of A$3,320.1 million and net income of A$318.7 million, alongside reaffirmed focus on acquisitions that meet strict return hurdles.
-   Management’s insistence on only pursuing bolt-on deals that can reach a 15% return on capital employed by year five offers insight into how ALS balances growth ambitions with disciplined capital allocation.
-   We’ll now explore how this earnings performance and disciplined 15% ROCE acquisition filter might reshape ALS’s existing investment narrative.

Uncover the next big thing with 60 elite penny stocks that balance risk and reward.

## ALS Investment Narrative Recap

To own ALS, you need to believe in the long term value of its global testing network and disciplined reinvestment, especially in Life Sciences and Minerals. The latest A$3,320.1 million revenue and A$318.7 million net income result confirms the business is still generating solid earnings, but the short term story still hinges on how well ALS manages margin pressure and integration risk from acquisitions. Management’s 15% ROCE hurdle for bolt ons does not materially change those near term risk and reward drivers.

The most relevant recent announcement is the full year 2026 result, because it sets the baseline from which any new bolt on acquisitions must earn that 15% ROCE by year five. With EBIT margins already under pressure from past deals and higher net interest costs, this disciplined filter could either protect returns or limit growth opportunities, depending on what actually clears the hurdle and how quickly new assets are integrated into the group.

Yet behind the disciplined 15% ROCE target, investors should be aware that margin dilution from acquisitions and rising debt costs could still...

Read the full narrative on ALS (it's free!)

ALS' narrative projects A$3.7 billion revenue and A$442.2 million earnings by 2028. This requires 6.8% yearly revenue growth and about A$186 million earnings increase from A$256.2 million today.

Uncover how ALS' forecasts yield a A$23.72 fair value, in line with its current price.

## Exploring Other Perspectives

ASX:ALQ 1-Year Stock Price Chart

Some of the most optimistic analysts were already assuming A$3.8 billion of revenue and A$489.6 million of earnings by 2028, so this disciplined 15% ROCE acquisition stance could either reinforce that bullish view or challenge it, depending on how you weigh the upside from further deals against the risk of technology disruption and in house testing eroding ALS’s long term edge.

Explore 3 other fair value estimates on ALS - why the stock might be worth just A$23.72!

## Reach Your Own Conclusion

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

-   A great starting point for your ALS research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.
-   Our free ALS research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate ALS' overall financial health at a glance.

## Looking For Alternative Opportunities?

Don't miss your shot at the next 10-bagger. Our latest stock picks just dropped:

-   Find 7 companies with promising cash flow potential yet trading below their fair value.
-   Rare earth metals are the new gold rush. Find out which 29 stocks are leading the charge.
-   Capitalize on the AI infrastructure supercycle with our selection of the 47 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

 *This article by Simply Wall St is general in nature. **We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.** It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.*

### **New:** Manage All Your Stock Portfolios in One Place

We've created the **ultimate portfolio companion** for stock investors, **and it's free.**

• Connect an unlimited number of Portfolios and see your total in one currency  
• Be alerted to new Warning Signs or Risks via email or mobile  
• Track the Fair Value of your stocks  

Try a Demo Portfolio for Free

### Related Stocks

- [ALQ.AU](https://longbridge.com/en/quote/ALQ.AU.md)

## Related News & Research

- [Is Sandfire Resources (ASX:SFR) Above Fair Value After Strong Results And Its Dividend Affirmation?](https://longbridge.com/en/news/297860811.md)
- [Is Magellan (ASX:MFG) Using Higher Dividends To Redefine Its Post-Earnings Capital Allocation Strategy?](https://longbridge.com/en/news/298011036.md)
- [Navigator Global Investments (ASX:NGI) Could Be 28% Undervalued On Earnings And Acquisition Plans](https://longbridge.com/en/news/297883177.md)
- [Stanmore Resources (ASX:SMR) Following Results And Guidance Reaffirmation Faces A Split Valuation View](https://longbridge.com/en/news/298082487.md)
- [Viva Energy Group (ASX:VEA) Could Be 7% Overvalued As Profit And Dividend Rebound](https://longbridge.com/en/news/297955654.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**